A Multicenter Assessment of ALD403 in Chronic Migraine
Trial ID or NCT#
The purpose of this study is to assess ALD403 in the prevention of migraine headache in chronic migraineurs.
Contact us to find out if this trial is right for you.
About this Clinical Trial
A Parallel Group, Double Blind Randomized Plaebo Controlled Dose Ranging Phase 2 Trial to Evaluate the Efficacy, Safety, and Pharmocokinetics of ALD403 Administered Intravenously in Patients with Chronic Migraine
Your Message Will Go ToMaria Coburn
Go Back To The Trial